Jennifer Hsuleejen Cao, MD
Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician · Dallas, TX
Jennifer Hsuleejen Cao, MD is a uveitis and ocular inflammatory disease (ophthalmology) physician with a practice address in Dallas, Texas, and NPI 1861718942, issued on Apr 14, 2010. Check the license (Texas Q3486, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Jennifer Hsuleejen Cao
- Credential
- MD
- Primary taxonomy
- Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician 207WX0108X
- License number
- Q3486 TX
Self-reported in NPPES; status is on the state search - Practice location
- 5303 Harry Hines Blvd FL 6, Dallas, TX 75390
- Phone
- (214) 645-2020
- Enumerated
- Apr 14, 2010
- Record last updated
- Apr 10, 2024
- Medicare enrollment
- Enrolled (PECOS I20150807013609); accepts Medicare assignment
- Medical or professional school
- Baylor College Of Medicine, 2010
- Entity
- Type 1 · individual
3 nearest uveitis and ocular inflammatory disease (ophthalmology) physician records → All 4 in Texas → Look up another NPI →
Also registered at 5303 Harry Hines Blvd FL 6
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Kambiz Ameli Zamani, MDNeuro-ophthalmology Physician1356048714
- Ashika Angirekula, MDOphthalmology Physician1366192742
- Jeremy Bartley, MDCornea and External Diseases Specialist Physician1467742270
- Aishwarya BhanOphthalmology Physician1538801063
- Jacob Blair, DOOphthalmology Physician1356918312
- Shibandri Das, MDOphthalmology Physician1932604535
Verify Jennifer Hsuleejen Cao in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license Q3486Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
55% fewer Medicare Part D claims than the average uveitis and ocular inflammatory disease (ophthalmology) physician in 2024
409 Medicare Part D claims for 81 beneficiaries, against an average of 916 among the 45 providers of this specialty who prescribed in Part D. Brand-name drugs were 37% of claims.
Most prescribed
- Methotrexate38 claims
- Mycophenolate Mofetil34 claims
- Humira(Cf) Pen29 claims
- Leucovorin Calcium29 claims
- Prednisolone Acetate28 claims
- Dorzolamide-Timolol25 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 74.6 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $147.98
1 payment: food and beverage; the largest payer was Bausch & Lomb Americas Inc. The 42 providers of this specialty with any payment received $10,742.06 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- University OF Texas Southwestern Medical Center AT DallasPlano, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician providers in Texas
There are 4 uveitis and ocular inflammatory disease (ophthalmology) physician records in Texas.
All 4 in Texas → Every provider in Dallas → Uveitis and Ocular Inflammatory Disease (Ophthalmology) Physician nationwide →
The 3 uveitis and ocular inflammatory disease (ophthalmology) physician records with the nearest ZIP codes
- Ashvini Reddy, M.D.San Antonio, TX 782311417102476
- David Scales, M.D.San Antonio, TX 782401164412029
- Saleema Kherani-Ali, MDAustin, TX 787121114487675
Common questions
What is Jennifer Hsuleejen Cao, MD's NPI number?
Jennifer Hsuleejen Cao, MD's National Provider Identifier (NPI) is 1861718942, issued on Apr 14, 2010. An NPI identifies a provider in billing; it is not a license.
Where is Jennifer Hsuleejen Cao, MD located?
The NPPES record lists a practice address at 5303 Harry Hines Blvd FL 6, Dallas, TX, 75390. Phone: (214) 645-2020. Providers update this record themselves, so call before visiting.
How can I verify Jennifer Hsuleejen Cao, MD's license?
NPPES lists Texas license number Q3486, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Jennifer Hsuleejen Cao, MD prescribe under Medicare Part D?
In 2024, Jennifer Hsuleejen Cao, MD had 409 Medicare Part D claims for 81 beneficiaries; the average among uveitis and ocular inflammatory disease (ophthalmology) physician prescribers was 916. Part D covers Medicare prescriptions only.
What is Jennifer Hsuleejen Cao, MD's MIPS final score?
The 2023 MIPS final score is 74.6 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.